Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2018-04-05 | Dr. Lanman received a Bachelor of Science degree in Chemistry from Stanford University and a Doctor of Medicine degree from Northwestern University. Dr. Lanman provides our Board with extensive business experience in biotechnology innovation, development and commercialization. |
| 2018-08-24 | Richard B. Lanman, M.D. |
| 2019-04-10 | Dr. Lanman received a Bachelor of Science degree in Chemistry from Stanford University and a Doctor of Medicine degree from Northwestern University. Dr. Lanman provides our Board with extensive business experience in biotechnology innovation, development and commercialization, as well as executive management experience. |
| 2020-04-23 | Dr. Lanman received a Bachelor of Science degree in Chemistry from Stanford University and a Doctor of Medicine degree from Northwestern University. |
| 2020-12-11 | The following table sets forth the beneficial ownership of shares of our common stock as of December 10, 2020 by (i) each current director... Richard B. Lanman, M.D.(1) 180,679 Owned Shares of Common Stock... (1) Director |
| 2021-04-19 | Dr. Lanman is the Chief Medical Officer of Guardant Health, Inc., a company specializing in non-invasive cancer diagnostics, based in Redwood City, California. From 2008 to 2014, Dr. Lanman was Chief Medical Officer of Veracyte, Inc., a genomic diagnostics company. He previously served as Chief Medical Officer for two diagnostics companies and as Senior Vice President and Medical Director of San Jose Medical Group. Dr. Lanman received a Bachelor of Science degree in Chemistry from Stanford University and a Doctor of Medicine degree from Northwestern University. |
| 2021-10-08 | Richard B. Lanman, M.D.(1) 561,014 shares owned, no mention of software or technical background. |
Data sourced from SEC filings. Last updated: 2025-07-01